<DOC>
	<DOCNO>NCT01046604</DOCNO>
	<brief_summary>In absence treatment , severe mitral valve regurgitation ( MR ) result leave atrium ( LA ) dilatation hypertrophy , follow ultimately left ventricular dysfunction heart failure . One promise intervention prevention deleterious effect pressure overload-induced cardiac hypertrophy heart failure dietary supplementation n-3 polyunsaturated fatty acid ( PUFAs ) . However , molecular target mechanisms n-3 PUFAs exert effect completely define . A possible target n-3 PUFAs mitochondrial membrane broad implication give mitochondrial dysfunction alter metabolism associate cardiac hypertrophy heart failure . The investigator recently identify significant mitochondrial dysfunction LA patient severe MR , compare non-hypertrophied right atrium ( RA ) . However , investigator address possibility intervention purify n-3 PUFAs ( Lovaza ) could improve mitochondrial function . From mechanistic perspective , investigator observe vitro n-3 PUFAs accumulate predominately mitochondrial membrane cardiomyocytes investigator believe exert effect biophysical organization membrane . Therefore , CENTRAL HYPOTHESIS administer Lovaza patient severe MR reduce apoptosis improve mitochondrial function LA ( Aim 1 ) . This change mitochondrial function drive significant biochemical biophysical remodel mitochondrial membrane ( Aim 2 ) .</brief_summary>
	<brief_title>Pilot Study Lovaza ( Omega 3 Fatty Acids ) Improve Cardiac Antioxidant/Anti-inflammatory Profile Before Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Mitral Valve Insufficiency</mesh_term>
	<criteria>Patients age 18+ undergo minimally invasive mitral valve repair surgery enrol study . Patients chronic renal insufficiency Chronic obstructive pulmonary disease Previous myocardial infarction Left ventricular dysfunction ( ejection fraction &lt; 40 % ) Use antiarrhythmic drug beta blocker , presence implantable defibrillator . In addition , patient high dietary intake fish ( â‰¥ 2 servings/week ) take n3 PUFA supplement exclude . Also , patient allergic fish shellfish , take anticoagulant/antiplatelet medication aspirin ( e.g . Plavix , Coumadin ) exclude study . Patients age 18 , woman pregnant exclude study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>mitral valve regurgitation</keyword>
	<keyword>omega 3 fatty acid</keyword>
	<keyword>fish oil</keyword>
	<keyword>cardiac</keyword>
	<keyword>mitochondrion</keyword>
	<keyword>apoptosis</keyword>
	<keyword>human heart</keyword>
</DOC>